The new question and arguably the more difficult one to answer is whether the employer's investment is actually working to deliver value
As of November 2025, nearly 80% (77.8%) of all Microdose GLP-1Rx users stayed engaged with the Noom app for 4 or more weeks, and D30 engagement for our December cohort was over 40% (43.6%), 1 which is at least 10 times higher than average health, medical, and fitness app retention
Toxicology
A doctor can assess your skin type, recommend the right dosage, and ensure the treatment is safe for you
Filed lawsuits allege that the manufacturers knew or should have known about their medications links to serious gastrointestinal disorders and have been accused of downplaying adverse events and failing to adequately warn doctors and patients of the dangers of their medications
Even with a drug like a GLP-1 that is so high-value and seems to be very effective, we still have these non-adherence challenges. Another challenge is the shifting marketplace for these drugs, with new GLP-1s being developed and pricing shifts likely